prostate%20cancer
PROSTATE CANCER

Prostate cancer is the cancer that occurs in the male's prostate.

It is the most common cancer in men >50 years of age.

Signs and symptoms include weak urinary stream, polyuria, nocturia, hematuria, erectile dysfunction, pelvic pain, back pain, chest pain, lower extremity weakness or numbness and loss of bowel or bladder control.

Drug Information

Indication: Locally advanced or metastatic breast cancer after failure of cytotoxic therapy. In combination w/ doxorubicin...

Jevtana
cabazitaxel

Indication: In combination w/ prednisone or prednisolone for hormone refractory metastatic prostate cancer previously trea...

Indication: Metastatic breast cancer. Advanced ovarian cancer in women who have failed a 1st-line platinum based chemother...

Indication: Breast, gastric, ovarian, small cell lung & superficial bladder (Tis, Ta) cancer, Non-Hodgkin's lymphoma, ...

Indication: Moderate to severe vasomotor symptoms associated w/ estrogen deficiency. Prevention & management of osteop...

Indication: Osteoporosis in postmenopausal women at increased risk of fracture. Increases bone mineral density & reduc...

Indication: Prevention of skeletal related events (pathological fracture, bone radiation, spinal cord compression or bone ...

Indication: Systemic fungal infections, skin, hair & nail infections induced by dermatophytes &/or yeasts.

Indication: Management of prostate cancer, breast cancer in premenopausal & perimenopausal women suitable for hormonal...

Indication: Management of prostate cancer suitable for hormonal manipulation.

2  /  6
Editor's Recommendations
Most Read Articles
03 Oct 2019
A short-term course of atorvastatin prior to radical prostatectomy does not yield significant benefits on the recovery of erectile function after the procedure, a recent study has found.